In the ever-evolving healthcare landscape, groundbreaking innovations often emerge to challenge the status quo.
I am a cancer doctor, and would love to see the disease caught earlier. Earlier detection typically translates into higher cure rates (with less intense treatment).
The recent approval by the U.S. Food and Drug Administration (FDA) for an investigational device study of the Galleri test marks a significant milestone in cancer screening.
The Galleri blood test can potentially revolutionize how we detect cancer. The approach offers a non-invasive and comprehensive approach that could change the narrative of early diagnosis.